Information and diffusion of new prescription drugs

Article English OPEN
Serra-Sastre, V. ; McGuire, A. (2013)

This article examines the role of different product information flows on the diffusion of new pharmaceuticals. Given the innovative nature of pharmaceutical drugs and their impact on health care expenditure there is a surprisingly small literature devoted to this topic. Some information flow mechanisms have been examined individually in the literature, but very few have captured the simultaneous impact of these mechanisms on up-take and diffusion. This article uses the up-take of statins as an example. Diffusion of this therapeutical group is expressed as a function of four specific informational channels: self-experience, consumption externalities, scientific evidence and marketing. In addition to this, the influence of economic factors is tested to examine whether they have any role in drug diffusion. Prescription data from over 130 General Practitioners (GP) practices in the UK during 1991–2004 are used to test the econometric specification applying dynamic panel data methods. Results suggest individual self-experience and clinical evidence are major factors promoting diffusion, while there is an inverse relationship with GP practice size and diffusion. Having controlled for these factors financial incentives and marketing appear to play little role.
  • References (17)
    17 references, page 1 of 2

    ARELLANO, M., and S. BOND (1991): "Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations," The Review of Economic Studies, 58, 277-297.

    AZOULAY, P. (2002): "Do Pharmaceutical Sales Respond to Scientific Evidence?," Journal of Economics & Management Strategy, 11, 551-594.

    BANERJEE, A. V. (1992): "A Simple Model of Herd Behavior," The Quarterly Journal of Economics, 107, 797-817.

    BERNDT, E. R., L. BUI, D. R. REILEY, and G. L. URBAN (1995): "Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market," The American Economic Review, 85, 100-105.

    BERNDT, E. R., L. T. BUI, D. H. LUCKING-REILEY, and G. L. URBAN (1997): "The Roles of Marketing, Product Quality, and Price Competition in the Growth and Composition of the U.S. Antiulcer Drug Industry," in The Economics of New Goods, ed. by T. F. Bresnahan, and R. J. Gordon. Chicago: The University of Chicago Press.

    BERNDT, E. R., R. S. PINDYCK, and P. AZOULAY (2003): "Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs," The Journal of Industrial Economics, 51, 243.

    BIKHCHANDANI, S., A. CHANDRA, D. GOLDMAN, and I. WELCH (2001): "The Economics of Iatroepidemics and Quakeries: Physician Learning, Informational Cascades and Geographic Variation in Medical Practice," Paper prepared for the 2001 NBER Summer Institute.

    BIKHCHANDANI, S., D. HIRSHLEIFER, and I. WELCH (1992): "A Theory of Fads, Fashion, Custom, and Cultural Change as Informational Cascades," The Journal of Political Economy, 100, 992-1026.

    BLUNDELL, R., and S. BOND (1998): "Initial Conditions and Moment Restrictions in Dynamic Panel Data Models," Journal of Econometrics, 87, 115-143.

    BOND, S. R. (2002): "Dynamic Panel Data Models: A Guide to Micro Data Methods and Practice," Portuguese Economic Journal, 1, 141-162.

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    120
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    City Research Online - IRUS-UK 0 120
Share - Bookmark